Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOLDEN7: SUN-101 vs Seebri PK Study in COPD
NCT02512302Phase 1Completed
- Sponsor
- Sunovion
- Start
- Oct 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of glycopyrrolate in chronic obstructive pulmonary disease (COPD) (5 arms), sponsored by Sunovion. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve from Time Zero to 24 Hours and 1 more. Started Oct 2015; status: completed.
02
Drugs
glycopyrrolate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02512302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02512302.